Suchen
Teva Pharmaceutical Industries Ltd
TEVAZur Watchlist hinzufügen
39.880USD
-0.180-0.45%
Trading geöffnet 09/22, 10:37（ET）
46.46BMarktkapitalisierung
32.38KGV TTM
Über {index_name} Teva Pharmaceutical Industries Ltd Unternehmen
Teva Pharmaceutical Industries Ltd is a Israeli-based pharmaceutical company. The Company operates through three segments: North America, Europe and International Markets. Each business segment manages entire product portfolio in its region, including generics, specialty and over-the-counter (OTC) products. In addition to these three segments, The Company has other activities, primarily the sale of active pharmaceutical ingredients (API) to third parties, certain contract manufacturing services and an out-licensing platform offering a portfolio of products to other pharmaceutical companies through its affiliate Medis.
Teva Pharmaceutical Industries Ltd Profil
BörsenkürzelTEVA
Name des UnternehmensTeva Pharmaceutical Industries Ltd
IPO-datumFeb 06, 2087
CEOFrancis (Richard D)
Anzahl der mitarbeiter33892
WertpapierartDepository Receipt
GeschäftsjahresendeFeb 06
Addresse124 Dvora Hanevi'a St.
StadtTEL AVIV-YAFO
BörseNASDAQ OMX NASDAQ Basic NYSE
LandIsrael
Postleitzahl6944020
Telefon97239148213
Websitehttps://www.tevapharm.com/
BörsenkürzelTEVA
IPO-datumFeb 06, 2087
CEOFrancis (Richard D)
Führungskräfte von Teva Pharmaceutical Industries Ltd
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Amir Elstein
Mr. Amir Elstein
Independent Director
Independent Director
2.12M
+0.68%
Mr. Richard D. Francis
Mr. Richard D. Francis
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
1.18M
+0.59%
Mr. Mark Sabag
Mr. Mark Sabag
Executive Vice President - International Markets Commercial
Executive Vice President - International Markets Commercial
885.93K
+11.77%
Dr. Sol J. Barer, Ph.D.
Dr. Sol J. Barer, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
448.01K
+4.85%
Mr. Richard Daniell
Mr. Richard Daniell
Executive Vice President - European Commercial
Executive Vice President - European Commercial
183.56K
-16.34%
Dr. Eric A. Hughes
Dr. Eric A. Hughes
Executive Vice President - Global R&D, Chief Medical Officer
Executive Vice President - Global R&D, Chief Medical Officer
134.88K
+20.14%
Mr. Gerald M. (Jerry) Lieberman
Mr. Gerald M. (Jerry) Lieberman
Independent Director
Independent Director
130.15K
+11.13%
Mr. Evan Lippman
Mr. Evan Lippman
Executive Vice President - Business Development
Executive Vice President - Business Development
130.04K
+33.98%
Ms. Rosemary A. (Rose) Crane
Ms. Rosemary A. (Rose) Crane
Independent Director
Independent Director
127.74K
+11.35%
Dr. Perry D. Nisen, M.D., Ph.D.
Dr. Perry D. Nisen, M.D., Ph.D.
Independent Director
Independent Director
119.81K
+12.10%
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Amir Elstein
Mr. Amir Elstein
Independent Director
Independent Director
2.12M
+0.68%
Mr. Richard D. Francis
Mr. Richard D. Francis
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
1.18M
+0.59%
Mr. Mark Sabag
Mr. Mark Sabag
Executive Vice President - International Markets Commercial
Executive Vice President - International Markets Commercial
885.93K
+11.77%
Dr. Sol J. Barer, Ph.D.
Dr. Sol J. Barer, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
448.01K
+4.85%
Mr. Richard Daniell
Mr. Richard Daniell
Executive Vice President - European Commercial
Executive Vice President - European Commercial
183.56K
-16.34%
Dr. Eric A. Hughes
Dr. Eric A. Hughes
Executive Vice President - Global R&D, Chief Medical Officer
Executive Vice President - Global R&D, Chief Medical Officer
134.88K
+20.14%
Häufig gestellte Fragen
Wer sind die fünf größten Anteilseigner von Teva Pharmaceutical Industries Ltd?
Die fünf größten Anteilseigner von Teva Pharmaceutical Industries Ltd sind: Mr. Amir Elstein
Wie viele Institutionen halten Anteile an Teva Pharmaceutical Industries Ltd (TEVA)?
Mit Stand vom 2026Q1 halten 1226 Institutionen Anteile an Teva Pharmaceutical Industries Ltd, mit einem Gesamtmarktwert von etwa 725.07M, was 62.27% der Gesamtanteile entspricht. Im Vergleich zum 2025Q4 ist der institutionelle Aktienbesitz um 9191465.00 gestiegen.
Was ist die größte Einnahmequelle von Teva Pharmaceutical Industries Ltd?
Am 2026Q1 erzielte das Geschäft mit Generic products für Teva Pharmaceutical Industries Ltd den höchsten Umsatz in Höhe von 2.10B, was 50.77% des Gesamtumsatzes entspricht.